Parallax Volatility Advisers’s Clover Health Investments CLOV Stock Holding History

Parallax Volatility Advisers’s Portfolio CLOV Stock Details CLOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,300	Closed	-$1.24K	–	1895
2023 Q4	$1.24K	Hold	1,300	–	–	﹤0.01%	2089
2023 Q3	$1.4K	Hold	1,300	–	–	﹤0.01%	2199
2023 Q2	$1.17K	Hold	1,300	–	–	﹤0.01%	2287
2023 Q1	$1.1K	Sell	1,300 -9,300	-88%	-$10.2K	﹤0.01%	2600
2022 Q4	$9.86K	Buy	+10,600	New	+$14.1K	﹤0.01%	2565
2022 Q3	–	Sell	-7,600	Closed	-$14K	–	3088
2022 Q2	$14K	Buy	+7,600	New	+$20.2K	﹤0.01%	2628
2022 Q1	–	Sell	-597,800	Closed	-$2.22M	–	2925
2021 Q4	$2.22M	Sell	597,800 -389,700	-39%	-$2.39M	﹤0.01%	1594
2021 Q3	$7.3M	Sell	987,500 -174,300	-15%	-$1.49M	0.01%	1082
2021 Q2	$15.5M	Sell	1,161,800 -514,100	-31%	-$5.05M	0.01%	727
2021 Q1	$12.7M	Buy	+1,675,900	New	+$18.9M	0.01%	835

Other funds holding CLOV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Parallax Volatility Advisers's CLOV Position: Q1 2025 in Review

Parallax Volatility Advisers sold out of Clover Health Investments (CLOV) in Q1 2025, closing a stake of 19,855 shares — an estimated $62.5K sold.

Parallax Volatility Advisers first reported a position in CLOV in Q1 2021 and held it in 10 quarters. The position peaked at $185K in Q4 2021. 202 funds tracked by Wall St. Rank hold CLOV as of Q1 2025.

Parallax Volatility Advisers reported no remaining Clover Health Investments position as of Q1 2025 after selling out during the quarter.
Parallax Volatility Advisers sold 19,855 Clover Health Investments shares in Q1 2025, an estimated $62.5K.
Parallax Volatility Advisers first reported a position in Clover Health Investments in Q1 2021 and held it in 10 quarters.
Parallax Volatility Advisers's Clover Health Investments position peaked at $185K in Q4 2021.
202 funds tracked by Wall St. Rank held Clover Health Investments as of Q1 2025.

Based on Parallax Volatility Advisers's 13F filing for Q1 2025, filed 15 May 2025.